Introduction
============

Induced pluripotent stem cells (iPSCs), which are reverted from somatic cells via nuclear transfer and transcription factor-based reprogramming, are pluripotent stem cells that are able to differentiate into all cell types ([@b1-mmr-17-03-4351]). They are successfully derived from somatic cells through viral transduction using the transcription factors sex-determining region Y-box 2, octamer-binding transcription factor 4 (*Oct4*), and either *NANOG* and lineage protein 28 ([@b2-mmr-17-03-4351]) or *c-MYC* and Krüppel-like factor 4 ([@b3-mmr-17-03-4351],[@b4-mmr-17-03-4351]). The treatment of end-stage liver disease is severely impaired by the shortage of potential organs, therefore, hepatocellular transplantation substituting for whole organ transplant may hold potential as an alternative treatment strategy ([@b5-mmr-17-03-4351]). Similar to embryonic stem cells (ESCs), iPSCs exhibit pluripotent properties and are able to differentiate into all cell lineages *in vitro*, including hepatocytes, suggesting that iPSCs may be a valuable cell source for hepatocellular transplantation ([@b6-mmr-17-03-4351],[@b7-mmr-17-03-4351]).

Several studies have investigated the mechanisms underlying differentiation of PSCs. The expression of the hepatic marker albumin has been reported to contribute to the efficient differentiation of iPSCs to hepatocyte-like cells ([@b8-mmr-17-03-4351]). Transforming growth factor-β has been revealed to correlate with the differentiation of iPSCs into functional endothelial cells, whereas the phosphatase and tensin homolog/Akt pathway targeted by microRNA (miR)-21 can assist the endothelial differentiation of iPSCs ([@b9-mmr-17-03-4351]). E-cadherin and several other crucial cell adhesion molecules, including classic cadherins, heparin sulfate proteoglycans, members of the immunoglobulin (IgG) superfamily and integrins, have been demonstrated to regulate the differentiation and survival of human PSCs, including human ESCs and iPSCs ([@b10-mmr-17-03-4351],[@b11-mmr-17-03-4351]). Through activating mesenchymal-to-epithelial transition, hepatocyte nuclear factor 4α (*HNF4A*) may be implicated in the generation of hepatocytes from human ESC-derived hepatoblasts, which may represent a favorable pathway for the efficient differentiation of human ESCs and iPSCs into functional hepatocytes ([@b12-mmr-17-03-4351]). Bone morphogenetic protein (*BMP*) is regulated by Brachyury and caudal-related homeobox 2 (*CDX2*), and mainly promotes mouse and human PSC differentiation to mesoderm, not trophoblasts ([@b13-mmr-17-03-4351]). However, the exact mechanisms guiding iPSC differentiation into hepatocytes remain to be elucidated.

Wilson *et al* ([@b14-mmr-17-03-4351]) investigated the differentially expressed genes (DEGs) in iPSCs derived from patients with liver disease and healthy subjects upon *in vitro* differentiation to hepatocytes, and identified 419 DEGs at false discovery rate (FDR) \<0.25 and 85 DEGs at FDR\<0.1. In the present study, using the more restrictive thresholds of adjusted P-value, i.e. FDR\<0.01 and \|log~2~fold change (FC)\|≥2, the DEGs between undifferentiated samples and definitive endoderm or early hepatocyte samples were identified, and their potential functions were predicted using enrichment analyses. Subsequently, the DEGs between the two groups were merged, and weighted correlation network analysis (WGCNA) was performed to identify gene clusters for the merged DEGs. Furthermore, the protein-protein interaction (PPI) networks for the DEGs belonging to the significant gene clusters were constructed, the common genes between the two comparison groups were identified, and their functional interaction (FI) network was analyzed.

Materials and methods
=====================

### Microarray data

The GSE66076 expression profile (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66076>) deposited by Wilson *et al* ([@b14-mmr-17-03-4351]), was downloaded from the National Center for Biotechnology Information Gene Expression Omnibus database, which was based on the GPL6244 \[HuGene-1_0-st\] Affymetrix Human Gene 1.0 ST Array \[transcript (gene) version\] platform. To study the differentiation mechanisms of iPSCs to hepatocytes, iPSCs across three stages of hepatic-directed differentiation were selected from GSE66076, including 3 undifferentiated (T0), 3 definitive endoderm (T5), and 3 early hepatocyte (T24) samples.

### Data preprocessing and DEG screening

Following the download of GSE66076, raw data was preprocessed with background correction, normalization and expression calculation by Oligo package ([@b15-mmr-17-03-4351]) in Bioconductor. The org.Hs.eg.db ([@b16-mmr-17-03-4351]) and hugene10sttranscriptcluster.db ([@b17-mmr-17-03-4351]) annotation packages were used to transform probe identifications (IDs) into gene symbols. For one gene symbol corresponding to several probe IDs, the mean value of probes was used as the final gene expression value.

The linear models for microarray data (limma) package ([@b18-mmr-17-03-4351]) in Bioconductor was applied to identify the DEGs between T0 and T5 or T24 samples. The P-values for the DEGs were calculated using the t-test method in the limma package and were then adjusted using the method described by Benjamini and Hochberg ([@b19-mmr-17-03-4351]). An FDR\<0.01 and \|log~2~FC\|≥2 were considered as the thresholds for significance.

### Functional and pathway enrichment analysis

The ToppGene database (<https://toppgene.cchmc.org/>) ([@b20-mmr-17-03-4351]) integrates pathway information in BioSystems \[including BioCyc, Kyoto Encyclopedia of Genes and Genomes (KEGG), REACTOME, WikiPathways\], GenMAPP, MSigDB C2 (including BioCarta, SigmaAldrich and Signaling Gateway), PantherDB, Pathway Ontology and Small Molecule Pathway Database databases, and can be used for functional and pathway enrichment analyses. Gene Ontology (GO, <http://www.geneontology.org/>) describes functions of genes and their products in molecular function (MF), biological process (BP) and cellular component (CC) aspects ([@b21-mmr-17-03-4351]). The KEGG (<http://www.genome.jp/kegg/>) database integrates chemical, genomic and systemic functional information of biological systems ([@b22-mmr-17-03-4351]). Combined with the ToppGene database, GO functional and KEGG pathway enrichment analyses were carried out for the DEGs between T0 and T5 samples, as well as those between T0 and T24 samples. An FDR≤0.05 and the involvement of at least 2 genes were used as the cut-off criteria.

### WGCNA analysis

WGCNA is usually applied for identifying highly correlated gene clusters, for summarizing the clusters using the intramodular hub gene or module eigengene, for linking modules to other modules and to external sample characteristics, and for calculating module membership measures ([@b23-mmr-17-03-4351]). The DEGs in the T0 vs. T5 and the T0 vs. T24 comparison groups were merged. Subsequently, the WGCNA package ([@b23-mmr-17-03-4351]) in R was used to identify gene clusters for the merged DEGs. The clusters with \|Correlation coefficient\|\>0.8 and P\<0.05 were identified as significant gene clusters.

### PPI network construction

The Search Tool for the Retrieval of Interacting Genes (STRING) database contains easily accessed and uniquely comprehensive experimental and predicted interaction information ([@b24-mmr-17-03-4351]). The STRING database (<http://string-db.org/>) ([@b24-mmr-17-03-4351]) was used to identify PPI relationships among the significant gene clusters, and a required confidence (combined score)\>0.7 was set as the cut-off criterion. Subsequently, the PPI network was visualized using the Cytoscape software (<http://www.cytoscape.org/>) ([@b25-mmr-17-03-4351]). The proteins in the network were represented as nodes, whereas their degrees corresponded to the number of edges associated with that node.

### Common gene analysis

The Venny 2.0 online tool (<http://bioinfogp.cnb.csic.es/tools/venny/index.html>) was used to identify the common genes between the two comparison groups. The gene FI network was constructed by merging interactions predicted using a machine learning approach with interactions extracted from human curated pathways ([@b24-mmr-17-03-4351]). ReactomeFI can be used for network-based data analysis through the highly reliable Reactome FI network ([@b26-mmr-17-03-4351]). According to the expression profiles data, the ReactomeFI plugin ([@b26-mmr-17-03-4351]) in Cytoscape was used to analyze the FI network for the common genes.

Results
=======

### DEG analysis

Using a threshold of FDR\<0.01 and \|log~2~FC\|≥2, the DEGs between T0 and T5 or T24 samples were investigated. Compared with T0 samples, 433 (including 268 upregulated and 165 downregulated genes) and 1,342 (including 729 upregulated and 613 downregulated genes) DEGs were identified in the T5 and T24 samples, respectively.

### Functional and pathway enrichment analysis

The upregulated genes in T5 samples were significantly enriched in 567 GO_BP terms, 12 GO_CC terms, 29 GO_MF terms and 7 KEGG pathways. The top 3 functions and pathways are presented in [Table I](#tI-mmr-17-03-4351){ref-type="table"}, including tissue development (GO_BP, FDR=2.70E-13), extracellular space (GO_CC, FDR=2.85E-07), molecular transducer activity (GO_MF, FDR=2.50E-04; which involved *HNF4A*) and extracellular matrix organization (pathway, FDR=1.10E-02). Meanwhile, the downregulated genes in T5 samples were significantly enriched in 3 GO_BP terms and 15 GO_CC terms, including cell-cell signaling (GO_BP, FDR=1.20E-02) and synapse (GO_CC, FDR=1.42E-03).

Upregulated genes in T24 samples were significantly enriched in 1,145 GO_BP terms, 88 GO_CC terms, 146 GO_MF terms and 142 KEGG pathways. The top 3 functions and pathways are presented in [Table II](#tII-mmr-17-03-4351){ref-type="table"}, including extracellular matrix organization (GO_BP, FDR=1.39E-21), extracellular space (GO_CC, FDR=8.05E-44), receptor binding (GO_MF, FDR=1.16E-11; which involved *HNF4A*) and complement and coagulation cascades (pathway, FDR=1.27E-16). Meanwhile, downregulated genes in T24 samples were significantly enriched in 317 GO_BP terms, 70 GO_CC terms, 41 GO_MF terms and 152 KEGG pathways. The top 3 functions and pathways are presented in [Table II](#tII-mmr-17-03-4351){ref-type="table"}, including cell cycle (GO_BP, FDR=1.55E-51), chromosome (GO_CC, FDR=1.18E-44), ribonucleotide binding (GO_MF, FDR=1.40E-07) and cell cycle (pathway, FDR=1.67E-49).

### WGCNA analysis

The DEGs in the T0 vs. T5 and T0 vs. T24 comparison groups were merged and 1,569 DEGs were obtained. Based on WGCNA, 3 gene clusters were identified, including blue (correlation coefficient, −0.98; P=3.07E-06), green (correlation coefficient, 0.25; P=5.16E-01), and turquoise (correlation coefficient, 0.89; P=1.14E-03) clusters ([Fig. 1](#f1-mmr-17-03-4351){ref-type="fig"}). Blue and turquoise gene clusters were significant.

The 504 DEGs in the blue cluster were significantly enriched in 274 GO_BP terms, 36 GO_CC terms and 33 KEGG pathways. The top 5 functions and pathways are presented in [Table III](#tIII-mmr-17-03-4351){ref-type="table"}, including regulation of multicellular organismal development (GO_BP; FDR=5.97E-06; which involved *BMP2*), chromosome (GO_CC, FDR=3.79E-03) and systemic lupus erythematosus (pathway, FDR=1.00E-03). Meanwhile, the 833 DEGs in the turquoise cluster were significantly enriched in 802 GO_BP terms, 87 GO_CC terms, 78 GO_MF terms and 166 KEGG pathways. The top 5 functions and pathways are presented in [Table IV](#tIV-mmr-17-03-4351){ref-type="table"}, including mitotic cell cycle \[GO_BP; FDR=3.93E-28; which involved cyclin-dependent kinase 1 (*CDK1*)\], extracellular space (GO_CC, FDR=3.10E-23), receptor binding (GO_MF, FDR=2.47E-04) and cell cycle (pathway, FDR=4.76E-16; which involved *CDK1*).

### PPI network analysis for genes in the blue and turquoise clusters

The PPI network for DEGs in the blue cluster demonstrated 218 nodes and 388 interactions ([Fig. 2](#f2-mmr-17-03-4351){ref-type="fig"}). In the PPI network, fibroblast growth factor 2 (FGF2, degree=14) and BMP2 (degree=12) were the nodes with the higher degrees, and FGF2 had interactions with BMP2 in the PPI network. Furthermore, the PPI network for DEGs in the turquoise cluster demonstrated 488 nodes and 1,803 interactions ([Fig. 3](#f3-mmr-17-03-4351){ref-type="fig"}). Notably, CDK1 (degree=71) was the node with the highest degree in the PPI network.

### Common gene analysis

A total of 202 common genes, including *HNF4A*, epidermal growth factor (*EGF*) and *FGF2* were identified between the two comparison groups, of which 100 were upregulated and 102 were downregulated ([Fig. 4](#f4-mmr-17-03-4351){ref-type="fig"}). According to the expression profile data of the common genes, a gene FI network was constructed ([Fig. 5A](#f5-mmr-17-03-4351){ref-type="fig"}). The top 11 most significant pathways enriched for the genes in the FI network are presented in [Fig. 5B](#f5-mmr-17-03-4351){ref-type="fig"}, and include the Ras signaling pathway (K), the Rap1 signaling pathway (K) and actions of nitric oxide in the heart (B). Notably, *EGF* and *FGF2* were enriched in the Ras (K) and Rap1 signaling pathways (K).

Discussion
==========

In the present study, 433 DEGs were identified between the T5 and T0 samples, including 268 up- and 165 downregulated genes, whereas 1,342 DEGs were identified between the T24 and T0 samples, including 729 up- and 613 downregulated genes. Based on WGCNA, blue and turquoise clusters were identified as significant gene clusters. A total of 202 common genes, including 100 up- and 102 downregulated genes, were identified between the two comparison groups, and a gene FI network was constructed.

In the PPI network for DEGs in the blue cluster, upregulated FGF2 (degree=14) and downregulated BMP2 (degree=12) were the nodes with the higher degrees. Exogenous *FGF2* has been reported to enhance the role of intracrine *FGF2* signaling in the maintenance of pluripotency; conversely, a downregulation of endogenous *FGF2* has been demonstrated during the differentiation of human ESCs, whereas its knockdown has been revealed to contribute to hESC differentiation ([@b27-mmr-17-03-4351],[@b28-mmr-17-03-4351]). It has previously been reported that FGF2 signaling controls *BMP4*-mediated hESCs differentiation by maintaining levels of *NANOG* via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway ([@b29-mmr-17-03-4351]). In the present study, functional enrichment of the DEGs in the blue cluster demonstrated that *BMP2* was enriched in the regulation of multicellular organismal development. Previous studies have reported that *BMP2* may participate in hESC differentiation through the control of an important early commitment step, which may provide the route for differentiation of pluripotent cells into neural precursors ([@b30-mmr-17-03-4351]). It has been revealed that *BMP-2/6* was more successful in inducing hESCs differentiation than *BMP-2* or *BMP-6*, and it was able to substitute these BMPs during *in vitro* differentiation guidance ([@b31-mmr-17-03-4351]). In addition, the FGF pathway serves an important role in directing the *BMP4*-induced generation of syncytiotrophoblasts from hESCs ([@b32-mmr-17-03-4351]). These findings suggested that *FGF2* and *BMP2* may serve key roles in the differentiation of iPSCs. In the PPI network for DEGs in the blue cluster, FGF2 could interact with BMP2, suggesting that *FGF2* may participate in iPSC differentiation through interacting with *BMP2*.

Upregulated CDK1 (degree=71) was the node with the highest degree in the PPI network for DEGs in the turquoise cluster. In human mesenchymal stem cells (MSCs), *CDK1* activation has been reported to facilitate the differentiation of MSCs into osteoblasts by phosphorylating the enhancer of zeste homologue 2 at Thr 487 ([@b33-mmr-17-03-4351]). Through promoting the binding between *Oct4* and the trophectoderm marker *CDX2*, *CDK1* has been demonstrated to prevent the generation of trophectoderm from ESCs and accordingly maintain stemness ([@b34-mmr-17-03-4351]). *CDK1* suppression conferred by p57, as well as the inhibition of the DNA damage response caused by p21, can trigger the differentiation of trophoblast stem cells into giant cells ([@b35-mmr-17-03-4351]). *CDK1/2* have been considered critical for the regulation of self-renewal and lineage specification of hESCs ([@b36-mmr-17-03-4351]). *CDK1* expression has been reported to markedly decrease during ESC differentiation, whereas its knockdown reduced the colony formation potential and proliferation of ESCs, suggesting that *CDK1* may contribute to maintaining the self-renewing and unique undifferentiated state of mouse ESCs ([@b37-mmr-17-03-4351]). In the present study, enrichment analysis for DEGs in the turquoise cluster revealed that *CDK1* was enriched in mitosis and cell cycle pathways. Therefore, it may be hypothesized that *CDK1* is involved in iPSC differentiation.

*HNF4A* and *EGF* were common genes between the two comparison groups, as they were revealed to be consistently downregulated in T5 and T24 samples. *HNF4A* serves an important role in specifying hepatic progenitor cells from hPSCs, via establishing the expression of the transcription factor network regulating the initiation of hepatocyte differentiation ([@b38-mmr-17-03-4351]). The miR-122/forkhead box A1/*HNF4A*-positive feedback loop has been reported to promote maturation and differentiation of mouse ESCs into hepatocytes, via controlling the balance between epithelial-to-mesenchymal and mesenchymal-to-epithelial transition, as well as the balance between differentiation and proliferation ([@b39-mmr-17-03-4351],[@b40-mmr-17-03-4351]). Previous studies demonstrated that *EGF* promoted proliferation of mouse ESCs through Ca^2+^ influx, phospholipase C-protein kinase C, and p44/42 mitogen-activated protein kinases signaling pathways, via the phosphorylation of the EGF receptor ([@b41-mmr-17-03-4351],[@b42-mmr-17-03-4351]). Heparin-binding epidermal growth factor-like growth factor can induce proliferation, as well as inhibit the adipogenic, chondrogenic and osteogenic differentiation of ESCs ([@b43-mmr-17-03-4351]). In the present study, enrichment analysis for genes in the FI network revealed that *EGF* was enriched in the Ras (K) and Rap1 signaling pathways (K). These results suggested that *HNF4A* and *EGF* may also be implicated in the differentiation of iPSCs into hepatocytes.

In conclusion, in the present study, a comprehensive bioinformatics analysis was performed to investigate the mechanisms involved in the differentiation of iPSCs to hepatocytes. A total of 433 and 1,342 DEGs were identified in T5 and T24 samples respectively, compared with T0 samples. The results indicated that *FGF2, BMP2, CDK1, HNF4A* and *EGF* may participate in the differentiation of iPSCs into hepatocytes. However, further experiments are required to elucidate their exact roles in the generation of hepatocytes from iPSCs.
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###### 

Top 3 functions and pathways enriched for differentially expressed genes in T5 samples.

  Category         ID           Description                           FDR        Gene no.   Gene symbol
  ---------------- ------------ ------------------------------------- ---------- ---------- ------------------------------------
  Upregulated                                                                               
    GO_BP          GO:0009888   tissue development                    2.70E-13   72         *HHEX*, *ARHGAP24*, *FOXQ1*......
                   GO:0072359   circulatory system development        2.88E-11   46         *EPHB3*, *HHEX*, *ARHGAP24*......
                   GO:0072358   cardiovascular system development     2.88E-11   46         *ADAM19*, *GATA4*, *GATA6*......
    GO_CC          GO:0005615   extracellular space                   2.85E-07   47         *PRSS2*, *RELN*, *ABCA1*......
                   GO:0002116   semaphorin receptor complex           2.12E-04     4        *NRP2*, *NRP1*, *PLXNA2*, *PLXNA4*
                   GO:0009897   external side of plasma membrane      5.50E-04   15         *ABCA1*, *DLK1*, *ITGA5*......
    GO_MF          GO:0060089   molecular transducer activity         2.50E-04   50         *EPHB3*, *ABCA1*, *WLS*......
                   GO:0004871   signal transducer activity            2.50E-04   50         *HNF4A*, *IL18R1*, *RXRG*......
                   GO:0004872   receptor activity                     7.51E-04   46         *SORCS1*, *FZD4*, *FZD8*......
    KEGG pathway   119526       other semaphorin interactions         5.42E-03     5        *SEMA6D*, *PLXNA2*, *SEMA5A*......
                   576262       extracellular matrix organization     1.10E-02   15         *PRSS2*, *MATN3*, *ITGA5*......
                   198832       adipogenesis                          5.42E-03   11         *SPOCK1*, *CYP26A1*, *GATA4*......
  Downregulated    GO:0007267   cell-cell signaling                   1.20E-02   28         *SOX2*, *LPAR3*, *SFRP2*......
    GO_BP          GO:0007268   synaptic transmission                 2.03E-02   20         *LPAR3*, *CHRNA9*, *RASGRF2*......
                   GO:0045766   positive regulation of angiogenesis   4.82E-02     7        *FLT1*, *SFRP2*, *VASH2*......
    GO_CC          GO:0045202   synapse                               1.42E-03   18         *NMNAT2*, *CHRNA9*, *GAP43*......
                   GO:0097060   synaptic membrane                     1.42E-03   11         *CHRNA9*, *GABRQ*, *CNKSR2*......
                   GO:0045211   postsynaptic membrane                 1.42E-03   10         *LRRTM3*, *VRL3*, *MET*......

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; MF, molecular function; FDR, false discovery rate.

###### 

Top 3 functions and pathways enriched for differentially expressed genes in T24 samples.

  Category         ID           Description                                FDR        Gene no.   Gene symbol                            
  ---------------- ------------ ------------------------------------------ ---------- ---------- -------------------------------------- --
  Upregulated                                                                                                                           
    GO_BP          GO:0030198   extracellular matrix organization          1.39E-21   66         *TTR*, *FAP*, *MFI2*......             
                   GO:0043062   extracellular structure organization       1.39E-21   66         *FBN1*, *EFEMP1*, *HPN*......          
                   GO:0009611   response to wounding                       6.97E-19   122        *CFH*, *EPHX2*, *SERPINA3*......       
    GO_CC          GO:0005615   extracellular space                        8.05E-44   165        *ABCA1*, *IL32*, *FSTL3*......         
                   GO:0031012   extracellular matrix                       1.34E-18   63         *SERPINF1*, *CHI3L1*, *F2*......       
                   GO:0005578   proteinaceous extracellular matrix         2.12E-17   55         *SERPINA1*, *FBN1*, *EFEMP1*......     
    GO_MF          GO:0005102   receptor binding                           1.16E-11   113        *EPHX2*, *ABCA1*, *IL32*......         
                   GO:1901681   sulfur compound binding                    6.03E-09   34         *CFH*, *ACADL*, *HNF4A*......          
                   GO:0050839   cell adhesion molecule binding             7.59E-09   29         *NDRG1*, *FGA*, *FGB*......            
    KEGG pathway   83073        complement and coagulation cascades        1.27E-16   28         *CFH*, *F2*, *F3*......                
                   198880       complement and coagulation cascades        7.64E-15   23         *SERPINA1*, *FGB*, *PLG*......         
                   M4470        extrinsic prothrombin activation pathway   7.08E-13   12         *FGB*, *FGG*, *SERPINC1*......         
  Downregulated    GO:0000278   mitotic cell cycle                         8.81E-55   141        *NUSAP1*, *CDKN3*, *KIF18A*......      
    GO_BP          GO:0007049   cell cycle                                 1.55E-51   180        *BRIP1*, *MIS18BP1*, *CENPW*......     
                   GO:0022402   cell cycle process                         1.06E-48   151        *CENPW*, *CENPE*, *CENPF*......        
    GO_CC          GO:0005694   chromosome                                 1.18E-44   116        *NUSAP1*, *CHAF1B*, *MIS18BP1*......   
                   GO:0044427   chromosomal part                           1.44E-36   97         *CHAF1B*, *MIS18BP1*, *CENPW*......    
                   GO:0032993   protein-DNA complex                        6.76E-32   62         *MIS18BP1*, *CENPW*, *CENPE*......     
    GO_MF          GO:0032559   adenyl ribonucleotide binding              1.40E-07   94         *KIF18A*, *BRIP1*, *CENPE*......       
                   GO:0005524   ATP binding                                1.40E-07   92         *ATAD5, MARK1, MCM2*......             
                   GO:0030554   adenyl nucleotide binding                  1.52E-07   94         *MCM4*, *PFAS*, *MCM5*......           
    KEGG           530733       cell cycle                                 1.67E-49   105        *KIF18A*, *PTTG1*, *MIS18BP1*......    
    pathway        105765       cell cycle, mitotic                        1.57E-35   81         *KIF18A*, *PTTG1*, *CENPE*......       
                   105750       G2/M checkpoints                           7.54E-21   24         *MCM2*, *MCM3*, *MCM4*......           

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; MF, molecular function; FDR, false discovery rate.

###### 

Top 5 functions and pathways enriched for differentially expressed genes in the blue cluster.

  Category   ID           Description                                          FDR        Gene no.   Gene symbol
  ---------- ------------ ---------------------------------------------------- ---------- ---------- --------------------------------------------
  GO_BP      GO:2000026   regulation of multicellular organismal development   5.97E-06   78         *CDKN2B*, *LPAR3*, *RAMP2*......
             GO:0001763   morphogenesis of a branching structure               1.17E-05   24         *FOXA1*, *FGF2*, *FGFR1*......
             GO:0048589   developmental growth                                 1.17E-05   30         *LPAR3*, *BCL11A*, *DRAXIN*......
             GO:0061138   morphogenesis of a branching epithelium              1.17E-05   23         *FOXA1*, *FGF2*, *FGFR1*......
             GO:0048754   branching morphogenesis of an epithelial tube        1.17E-05   21         *FOXA1*, *FGF2*, *COL4A1*......
  GO_CC      GO:0044420   extracellular matrix component                       1.46E-03   15         *COL4A1*, *COL4A2*, *COL4A5*......
             GO:0000785   chromatin                                            2.27E-03   26         *MCM2*, *HIST1H2AJ*, *HIST1H2AB*......
             GO:0005604   basement membrane                                    2.36E-03   12         *COL4A1*, *COL4A2*, *COL4A5*......
             GO:0005694   chromosome                                           3.79E-03   40         *MCM2*, *MCM3*, *HIST1H4I*......
             GO:0044427   chromosomal part                                     4.60E-03   35         *MCM2*, *MCM3*, *HIST1H2AJ*......
  KEGG       106540       telomere maintenance                                 7.80E-04   13         *HIST1H4I*, *HIST1H2AJ*, *HIST1H2AB*......
  pathway    366238       amyloids                                             9.81E-04   13         *HIST1H4I*, *HIST1H2AJ*, *HIST1H2AB*......
             106548       packaging of telomere ends                           9.81E-04   10         *HIST1H4I*, *HIST1H2AJ*, *HIST1H2AB*......
             477134       meiotic synapsis                                     9.81E-04   12         *HIST1H4I*, *HIST1H2AJ*, *HIST1H2AB*......
             83122        systemic lupus erythematosus                         1.00E-03   16         *HLA-DOA*, *HIST1H4I*, *HIST1H2AJ*......

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; FDR, false discovery rate.

###### 

Top 5 functions and pathways enriched for differentially expressed genes in the turquoise cluster.

  Category   ID           Description                                    FDR        Gene no.   Gene symbol
  ---------- ------------ ---------------------------------------------- ---------- ---------- ----------------------------------------
  GO_BP      GO:0000278   mitotic cell cycle                             3.93E-28   127        *NUSAP1*, *KIF18A*, *MIS18BP1*......
             GO:0007067   mitotic nuclear division                       1.58E-26   77         *CENPW*, *SPC25*, *SGOL1*......
             GO:0000280   nuclear division                               1.61E-25   90         *FANCD2*, *NDC80*, *MKI67*......
             GO:1903047   mitotic cell cycle process                     8.19E-25   111        *MCM10*, *RRM2*, *EZH2*......
             GO:0048285   organelle fission                              7.14E-24   90         *SPC24*, *RUVBL1*, *TPX2*......
  GO_CC      GO:0005615   extracellular space                            3.10E-23   141        *SERPINA3*, *FSTL3*, *ACTA2*......
             GO:0000775   chromosome, centromeric region                 1.99E-16   39         *MIS18BP1*, *CENPW*, *HJURP*......
             GO:0005694   chromosome                                     9.93E-16   90         *CENPW*, *HJURP*, *SPC25*......
             GO:0000793   condensed chromosome                           3.71E-15   40         *SPC24*, *CDCA5*, *CENPK*......
             GO:0000779   condensed chromosome, centromeric region       7.92E-15   28         *BUB1*, *BUB1B*, *KIF2C*......
  GO_MF      GO:0005102   receptor binding                               2.47E-04   100        *EPHX2*, *S100A14*, *F2*......
             GO:0030414   peptidase inhibitor activity                   2.47E-04   24         *SERPINA3*, *RPS6KA3*, *CD109*......
             GO:0004867   serine-type endopeptidase inhibitor activity   2.47E-04   17         *SERPINA3*, *CD109*, *AGT*......
             GO:0004866   endopeptidase inhibitor activity               2.47E-04   23         *SERPINA3*, *RPS6KA3*, *CD109*......
             GO:0061135   endopeptidase regulator activity               3.74E-04   23         *AGT, AHSG*, *AMBP*, *SERPINA11*......
  KEGG       530733       cell cycle                                     4.76E-16   80         *KIF18A*, *MIS18BP1*, *HJURP*......
  pathway    105765       cell cycle, mitotic                            1.16E-14   68         *KIF18A*, *SPC25*, *MCM5*......
             83073        complement and coagulation cascades            1.44E-13   26         *FGB*, *FGG*, *SERPINC1*......
             105815       mitotic prometaphase                           2.98E-12   31         *KIF18A*, *SPC25*, *SGOL1*......
             198880       complement and coagulation cascades            8.46E-12   21         *FGB*, *SERPINC1*, *C1S*......

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; MF, molecular function; FDR, false discovery rate.
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